Accelerate your clinical trials and therapeutic development with IQVIA Laboratories, your trusted partner in Genomic Companion Diagnostics (CDx). For over 20 years, we’ve led the way in precision medicine, delivering biomarker-driven insights and harmonized testing across three continents.
Why IQVIA Laboratories?
- Global Expertise: Extensive experience with the top 10 pharmaceutical companies and partnerships with over 125 leading biotech innovators.
- Rapid Turnaround: Results delivered to clinical sites within 10–12 business days for NGS testing—speed without compromise.
- Comprehensive Capabilities: From Next Generation Sequencing (NGS) to molecular, IHC, and FISH technologies, our labs support every stage of CDx development.
- End-to-End Support: Dedicated regulatory specialists, global project managers, and a network of 30+ board-certified pathologists ensure scientific leadership and operational excellence.
- Flexible Models: Expertise in both IVD and Laboratory Developed Test (LDT) pathways, including tumor-agnostic therapies and global regulatory navigation.
- Massive Data Delivery: Over 1.2 petabytes of genomic data delivered globally in 2024.
Success Stories
- Fast, global sample processing for multicenter oncology trials.
- Seamless collaboration with IVD and pharma partners for comprehensive assay development.
- Proven track record in supporting regulatory submissions and expanding patient access worldwide.
Integrated Solutions for Every Trial Streamline your CDx clinical trials with IQVIA Laboratories harmonized biomarker testing, logistics, and data management—eliminating the need for multiple vendors.
Ready to advance your precision medicine program? Contact IQVIA Laboratories today.
Complete the form below to access this insight brief.
Related Insights
Reproducibility Challenges in an era of Massive Data
Presented at the MCBIOS & MAQC 2021 Joint Conference
A Verified Genomic Reference Sample for Assessing Performance of Cancer Panels Detecting Small Variants of Low Allele Frequency
Presented at the MCBIOS & MAQC 2021 Joint Conference
Unexpected Impacts to Library Complexity After DNA and RNA Library Preparation in Illumina Next Generation Sequencing
Presented at the MCBIOS & MAQC 2021 Joint Conference
Immune Landscape Signatures for Characterization of Tumor Microenvironment and Response to Therapy
Gene expression and analysis for detection of 38 Immune Landscape Signatures
Using Gene Signature Methodologies to Strengthen Immuno-Oncology Trials
Genomic technologies that empower and enhance immuno-oncology trials
Laboratory Solutions for Hepatitis B (HBV) Clinical Trials
Insight brief by Joseph Sebastian, Ph.D., Scientific Advisor, Infectious & Liver Diseases
Enabling blood sample prep for single cell sequencing in clinical research
The Role of Genomics in Clinical Trials with Patrick Hurban
I-O clinical development podcast series
IQVIA Laboratories Corporate Brochure
A global drug discovery and development laboratory services organization
Evaluating and Implementing SARS-CoV-2 PCR Tests for Diagnostic and Clinical Trial Use
AAPS 2020 COVID-19 Workshop: Current Pharmaceutical Developments for Cures and Prevention
